H<sub>2</sub>S‐Releasing Versatile Montmorillonite Nanoformulation Trilogically Renovates the Gut Microenvironment for Inflammatory Bowel Disease Modulation
2024 · Advanced Science · 72 citations
https://doi.org/10.1002/advs.202308092
H
Hongyang Lu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
1.4K
Citations
22
h-index
43
i10-index
Hongyang Lu is an academic researcher from Xinyang Normal University. The author has contributed to research in topics: Lung Cancer Research Studies & Lung Cancer Treatments and Mutations & Neuroendocrine Tumor Research Advances. The author has an h-index of 22, co-authored 103 publications.
ORCID: 0000-0003-0404-5153Papers by this author
worksEffects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
2017 · Scientific Reports · 43 citations
https://doi.org/10.1038/srep45193
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
2018 · BMC Cancer · 29 citations
https://doi.org/10.1186/s12885-018-4159-2
L718Q/V mutation in exon 18 of EGFR mediates resistance to osimertinib: clinical features and treatment
2022 · Discover Oncology · 12 citations
https://doi.org/10.1007/s12672-022-00537-7
Nuclear protein in testis carcinoma of the lung
2023 · Translational Oncology · 12 citations
https://doi.org/10.1016/j.tranon.2023.101640
MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma
2018 · World Journal of Surgical Oncology · 10 citations
https://doi.org/10.1186/s12957-018-1413-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat